Search research articles
Contact Us
Filters
Showing results (671-680 of 748) with videos related to
Page
of 75
Sort By:
Scientific Reports
|
September 19, 2013
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties
Joseph H Taube, Gabriel G Malouf, Emily Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 17, 2015
Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch
Diana N Nunes, Emmanuel Dias-Neto, Marina Cardó-Vila, et al.
Haematologica
|
November 10, 2018
The involvement of microRNA in the pathogenesis of Richter syndrome
Katrien Van Roosbroeck, Recep Bayraktar, Steliana Calin, et al.
Oncogene
|
August 8, 2017
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model
L D'Abundo, E Callegari, A Bresin, et al.
The Journal of Rheumatology
|
May 22, 2001
Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group
J M Berthelot, M Klarlund, D McGonagle, et al.
Oncotarget
|
October 1, 2013
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
Roxana S Redis, Anieta M Sieuwerts, Maxime P Look, et al.
Journal of the National Cancer Institute
|
June 30, 2014
Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma
Shuo Xu, Jun Wei, Fei Wang, et al.
Ebiomedicine
|
May 4, 2017
Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections
Enrique Fuentes-Mattei, Dana Elena Giza, Masayoshi Shimizu, et al.
Molecular Therapy. Nucleic Acids
|
January 18, 2019
The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers
Hamada A Mokhlis, Recep Bayraktar, Nashwa N Kabil, et al.
Ebiomedicine
|
January 24, 2020
Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112]
Pinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Page
of 75
Search research articles
Search
Showing results (671-680 of 748) with videos related to
Sort By:
Page
of 75
Scientific Reports
|
September 19, 2013
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties
Joseph H Taube, Gabriel G Malouf, Emily Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 17, 2015
Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch
Diana N Nunes, Emmanuel Dias-Neto, Marina Cardó-Vila, et al.
Haematologica
|
November 10, 2018
The involvement of microRNA in the pathogenesis of Richter syndrome
Katrien Van Roosbroeck, Recep Bayraktar, Steliana Calin, et al.
Oncogene
|
August 8, 2017
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model
L D'Abundo, E Callegari, A Bresin, et al.
The Journal of Rheumatology
|
May 22, 2001
Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group
J M Berthelot, M Klarlund, D McGonagle, et al.
Oncotarget
|
October 1, 2013
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
Roxana S Redis, Anieta M Sieuwerts, Maxime P Look, et al.
Journal of the National Cancer Institute
|
June 30, 2014
Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma
Shuo Xu, Jun Wei, Fei Wang, et al.
Ebiomedicine
|
May 4, 2017
Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections
Enrique Fuentes-Mattei, Dana Elena Giza, Masayoshi Shimizu, et al.
Molecular Therapy. Nucleic Acids
|
January 18, 2019
The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers
Hamada A Mokhlis, Recep Bayraktar, Nashwa N Kabil, et al.
Ebiomedicine
|
January 24, 2020
Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112]
Pinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Page
of 75